Be the first to review “Xtate
Enzalutamide”
Enzalutamide”
Xtate
Enzalutamide
INDICATIONS:
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) with ADT. High-risk Non-Metastatic Castration-Resistant Prostate Cancer (nmCRPC). Metastatic Castration-Resistant Prostate Cancer (mCRPC) pre/post-chemotherapy.
Packaging: Box of 28’s
Shelf Life: 36 mos
Origin: India
Dosage Form: (ORALS)
Reviews
There are no reviews yet.